newsfilter
← Latest News
Business Wire·

Intersect ENT Reports Third Quarter 2021 Financial Results

Intersect ENT, Inc. (NASDAQ:XENT), a global ear, nose and throat ("ENT") medical technology leader dedicated to transforming patient care, today reported financial results for the third quarter ended September 30, 2021. Total revenue was $24.4 millio